Lotus Health Group Co
Lotus Holdings Co.,Ltd. engages in the production and sale of condiments and health food in China. The company offers soy sauce, oyster sauce, vinegar, cooking wine, braised sauce, and sesame oil; chicken essence, chicken powder, chicken juice, seasoning, dumpling materials, fried vegetables, and fresh mushroom, as well as octagonal, white pepper, black pepper, ang cumin powder. It also provides … Read more
Lotus Health Group Co (600186) - Net Assets
Latest net assets as of September 2025: CN¥1.74 Billion CNY
Based on the latest financial reports, Lotus Health Group Co (600186) has net assets worth CN¥1.74 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.27 Billion) and total liabilities (CN¥1.54 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.74 Billion |
| % of Total Assets | 53.03% |
| Annual Growth Rate | 6.44% |
| 5-Year Change | 904.06% |
| 10-Year Change | 12530.22% |
| Growth Volatility | 170.47 |
Lotus Health Group Co - Net Assets Trend (1995–2024)
This chart illustrates how Lotus Health Group Co's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Lotus Health Group Co (1995–2024)
The table below shows the annual net assets of Lotus Health Group Co from 1995 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.52 Billion | +14.11% |
| 2023-12-31 | CN¥1.33 Billion | +12.80% |
| 2022-12-31 | CN¥1.18 Billion | +0.64% |
| 2021-12-31 | CN¥1.17 Billion | +675.10% |
| 2020-12-31 | CN¥150.96 Million | +105.20% |
| 2019-12-31 | CN¥73.57 Million | +114.86% |
| 2018-12-31 | CN¥-494.92 Million | -346.76% |
| 2017-12-31 | CN¥-110.78 Million | -471.39% |
| 2016-12-31 | CN¥29.83 Million | +148.55% |
| 2015-12-31 | CN¥12.00 Million | -97.85% |
| 2014-12-31 | CN¥558.65 Million | +0.85% |
| 2013-12-31 | CN¥553.92 Million | -37.91% |
| 2012-12-31 | CN¥892.18 Million | +4.44% |
| 2011-12-31 | CN¥854.27 Million | -35.11% |
| 2010-12-31 | CN¥1.32 Billion | +1.71% |
| 2009-12-31 | CN¥1.29 Billion | +16.85% |
| 2008-12-31 | CN¥1.11 Billion | -21.46% |
| 2007-12-31 | CN¥1.41 Billion | -9.57% |
| 2006-12-31 | CN¥1.56 Billion | -20.54% |
| 2005-12-31 | CN¥1.96 Billion | +0.24% |
| 2004-12-31 | CN¥1.96 Billion | -0.09% |
| 2003-12-31 | CN¥1.96 Billion | -6.76% |
| 2002-12-31 | CN¥2.10 Billion | +1.79% |
| 2001-12-31 | CN¥2.07 Billion | +42.69% |
| 2000-12-31 | CN¥1.45 Billion | +13.47% |
| 1999-12-31 | CN¥1.28 Billion | +11.92% |
| 1998-12-31 | CN¥1.14 Billion | +269.07% |
| 1997-12-31 | CN¥308.76 Million | +15.34% |
| 1996-12-31 | CN¥267.70 Million | +8.01% |
| 1995-12-31 | CN¥247.85 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Lotus Health Group Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 117626693100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥1.79 Billion | 105.74% |
| Other Comprehensive Income | CN¥102.71 Million | 6.05% |
| Other Components | CN¥976.11 Million | 57.52% |
| Total Equity | CN¥1.70 Billion | 100.00% |
Lotus Health Group Co Competitors by Market Cap
The table below lists competitors of Lotus Health Group Co ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Perella Weinberg Partners
NASDAQ:PWP
|
$1.08 Billion |
|
Korea Gas Corporation
KO:036460
|
$1.08 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
$1.08 Billion |
|
Ujjivan Small Finance Bank Limited
NSE:UJJIVANSFB
|
$1.08 Billion |
|
Europris ASA
OL:EPR
|
$1.08 Billion |
|
Excelerate Energy Inc
NYSE:EE
|
$1.08 Billion |
|
Smithfield Foods, Inc. Common Stock
NASDAQ:SFD
|
$1.08 Billion |
|
Grupo Supervielle SA
NYSE:SUPV
|
$1.08 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lotus Health Group Co's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,538,472,106 to 1,697,120,428, a change of 158,648,322 (10.3%).
- Net income of 202,582,846 contributed positively to equity growth.
- Dividend payments of 28,563,196 reduced retained earnings.
- Share repurchases of 73,255,590 reduced equity.
- Other comprehensive income increased equity by 102,681,820.
- Other factors decreased equity by 44,797,558.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥202.58 Million | +11.94% |
| Dividends Paid | CN¥28.56 Million | -1.68% |
| Share Repurchases | CN¥73.26 Million | -4.32% |
| Other Comprehensive Income | CN¥102.68 Million | +6.05% |
| Other Changes | CN¥-44.80 Million | -2.64% |
| Total Change | CN¥- | 10.31% |
Book Value vs Market Value Analysis
This analysis compares Lotus Health Group Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.00x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 25.91x to 6.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1995-12-31 | CN¥0.23 | CN¥6.03 | x |
| 1996-12-31 | CN¥0.25 | CN¥6.03 | x |
| 1997-12-31 | CN¥0.29 | CN¥6.03 | x |
| 1998-12-31 | CN¥1.07 | CN¥6.03 | x |
| 1999-12-31 | CN¥1.20 | CN¥6.03 | x |
| 2000-12-31 | CN¥1.36 | CN¥6.03 | x |
| 2001-12-31 | CN¥1.94 | CN¥6.03 | x |
| 2002-12-31 | CN¥1.96 | CN¥6.03 | x |
| 2003-12-31 | CN¥1.82 | CN¥6.03 | x |
| 2004-12-31 | CN¥1.82 | CN¥6.03 | x |
| 2005-12-31 | CN¥1.83 | CN¥6.03 | x |
| 2006-12-31 | CN¥1.46 | CN¥6.03 | x |
| 2007-12-31 | CN¥1.33 | CN¥6.03 | x |
| 2008-12-31 | CN¥1.07 | CN¥6.03 | x |
| 2009-12-31 | CN¥1.22 | CN¥6.03 | x |
| 2010-12-31 | CN¥1.25 | CN¥6.03 | x |
| 2011-12-31 | CN¥0.81 | CN¥6.03 | x |
| 2012-12-31 | CN¥0.85 | CN¥6.03 | x |
| 2013-12-31 | CN¥0.55 | CN¥6.03 | x |
| 2014-12-31 | CN¥0.50 | CN¥6.03 | x |
| 2015-12-31 | CN¥0.09 | CN¥6.03 | x |
| 2016-12-31 | CN¥0.13 | CN¥6.03 | x |
| 2017-12-31 | CN¥0.03 | CN¥6.03 | x |
| 2018-12-31 | CN¥-0.22 | CN¥6.03 | x |
| 2019-12-31 | CN¥0.23 | CN¥6.03 | x |
| 2020-12-31 | CN¥0.28 | CN¥6.03 | x |
| 2021-12-31 | CN¥0.95 | CN¥6.03 | x |
| 2022-12-31 | CN¥0.79 | CN¥6.03 | x |
| 2023-12-31 | CN¥0.83 | CN¥6.03 | x |
| 2024-12-31 | CN¥1.01 | CN¥6.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lotus Health Group Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.94%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.65%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 2.14x
- Recent ROE (11.94%) is above the historical average (-23.92%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1995 | 20.81% | 3.99% | 1.78x | 2.93x | CN¥26.80 Million |
| 1996 | 20.59% | 3.73% | 1.68x | 3.29x | CN¥28.34 Million |
| 1997 | 32.60% | 6.54% | 1.51x | 3.30x | CN¥69.78 Million |
| 1998 | 8.81% | 8.22% | 0.69x | 1.55x | CN¥-13.54 Million |
| 1999 | 13.22% | 13.56% | 0.49x | 1.98x | CN¥41.03 Million |
| 2000 | 11.87% | 13.11% | 0.42x | 2.14x | CN¥27.10 Million |
| 2001 | 7.04% | 10.48% | 0.32x | 2.09x | CN¥-61.10 Million |
| 2002 | 0.93% | 1.58% | 0.26x | 2.21x | CN¥-189.11 Million |
| 2003 | -7.50% | -12.39% | 0.25x | 2.40x | CN¥-339.27 Million |
| 2004 | 0.24% | 0.48% | 0.21x | 2.32x | CN¥-189.12 Million |
| 2005 | 0.50% | 0.73% | 0.31x | 2.20x | CN¥-184.75 Million |
| 2006 | 0.67% | 0.56% | 0.49x | 2.46x | CN¥-145.52 Million |
| 2007 | 0.88% | 0.56% | 0.58x | 2.69x | CN¥-128.68 Million |
| 2008 | 1.13% | 0.61% | 0.59x | 3.14x | CN¥-98.29 Million |
| 2009 | 14.73% | 7.69% | 0.69x | 2.76x | CN¥61.27 Million |
| 2010 | 1.33% | 0.65% | 0.82x | 2.48x | CN¥-114.32 Million |
| 2011 | -53.37% | -16.62% | 0.94x | 3.43x | CN¥-545.02 Million |
| 2012 | 4.03% | 1.44% | 0.90x | 3.10x | CN¥-54.09 Million |
| 2013 | -56.39% | -15.26% | 0.83x | 4.46x | CN¥-387.57 Million |
| 2014 | 3.98% | 1.19% | 0.76x | 4.39x | CN¥-36.11 Million |
| 2015 | -556.61% | -28.63% | 0.79x | 24.58x | CN¥-517.62 Million |
| 2016 | 47.43% | 3.69% | 0.85x | 15.09x | CN¥51.49 Million |
| 2017 | -302.95% | -5.58% | 0.98x | 55.33x | CN¥-106.85 Million |
| 2018 | 0.00% | -19.23% | 1.01x | 0.00x | CN¥-302.69 Million |
| 2019 | 22.27% | 4.07% | 0.79x | 6.92x | CN¥38.14 Million |
| 2020 | 19.28% | 4.49% | 1.10x | 3.90x | CN¥35.76 Million |
| 2021 | 3.16% | 2.44% | 0.80x | 1.61x | CN¥-96.22 Million |
| 2022 | 3.27% | 2.73% | 0.70x | 1.72x | CN¥-95.05 Million |
| 2023 | 8.45% | 6.18% | 0.86x | 1.58x | CN¥-23.92 Million |
| 2024 | 11.94% | 7.65% | 0.73x | 2.14x | CN¥32.87 Million |
Industry Comparison
This section compares Lotus Health Group Co's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $1,271,150,340
- Average return on equity (ROE) among peers: 17.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lotus Health Group Co (600186) | CN¥1.74 Billion | 20.81% | 0.89x | $1.08 Billion |
| Shenzhen Shenbao Industrial Co Ltd (000019) | $296.34 Million | 13.18% | 0.58x | $322.05 Million |
| Xiwang Foodstuffs Co Ltd (000639) | $135.06 Million | 5.79% | 0.97x | $334.27 Million |
| Nanfang Black Sesame Group Co Ltd (000716) | $1.74 Billion | 8.58% | 0.63x | $341.35 Million |
| CNFC Overseas Fishery Co Ltd (000798) | $655.17 Million | 3.96% | 0.09x | $419.13 Million |
| Henan Shuanghui Investment & Development Co Ltd (000895) | $2.19 Billion | 12.06% | 0.42x | $3.99 Billion |
| Xinjiang Chalkis Co Ltd (000972) | $425.35 Million | 6.38% | 1.44x | $202.97 Million |
| Zhengzhou Qianweiyangchu Food Co Ltd (001215) | $1.82 Billion | 4.59% | 0.27x | $263.05 Million |
| Wenzhou Yuanfei Pet Toy Products Co. Ltd. A (001222) | $1.25 Billion | 12.64% | 0.11x | $161.52 Million |
| Guangdong Yuehai Feeds Group Co.Ltd. (001313) | $2.57 Billion | -3.32% | 0.86x | $168.08 Million |
| Shandong Oriental Ocean Sci-Tech Co Ltd (002086) | $1.63 Billion | 107.55% | 0.66x | $445.69 Million |